Sara Matricardi

Chieti, 66100, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications

Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsy.

Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsy.

Journal: Epilepsy & behavior : E&B
Published: February 10, 2026

Electrographic-only seizures and status epilepticus in neonates with Tuberous Sclerosis Complex.

Electrographic-only seizures and status epilepticus in neonates with Tuberous Sclerosis Complex.

Journal: Pediatric research
Published: January 18, 2026

Predicting epilepsy after new onset refractory status epilepticus due to autoimmune encephalitis: The DAME score.

Predicting epilepsy after new onset refractory status epilepticus due to autoimmune encephalitis: The DAME score.

Journal: Epilepsia
Published: October 05, 2025

Effectiveness and safety of perampanel by concomitant antiseizure medications: Insights from the real-world PERMIT Extension study.

Effectiveness and safety of perampanel by concomitant antiseizure medications: Insights from the real-world PERMIT Extension study.

Journal: Epilepsy & behavior : E&B
Published: May 22, 2025

Is highly purified cannabidiol a treatment opportunity for drug-resistant epilepsy in subjects with typical Rett syndrome and CDKL5 deficiency disorder?

Is highly purified cannabidiol a treatment opportunity for drug-resistant epilepsy in subjects with typical Rett syndrome and CDKL5 deficiency disorder?

Journal: Epilepsia open
Published: March 12, 2025

Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study.

Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study.

Journal: Journal of neurology
Published: February 21, 2025

Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real-world study.

Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real-world study.

Journal: Epilepsia
Published: January 05, 2025

Fenfluramine treatment for Dravet syndrome: Long term real-world analysis demonstrates safety and reduced health care burden.

Fenfluramine treatment for Dravet syndrome: Long term real-world analysis demonstrates safety and reduced health care burden.

Journal: Epilepsia
Published: November 22, 2024

Correction to: CDKL5 deficiency-related neurodevelopmental disorders: a multi-center cohort study in Italy.

Correction to: CDKL5 deficiency-related neurodevelopmental disorders: a multi-center cohort study in Italy.

Journal: Journal of neurology
Published: October 30, 2024

Exploring the Landscape of Pre- and Post-Synaptic Pediatric Disorders with Epilepsy: A Narrative Review on Molecular Mechanisms Involved.

Exploring the Landscape of Pre- and Post-Synaptic Pediatric Disorders with Epilepsy: A Narrative Review on Molecular Mechanisms Involved.

Journal: International journal of molecular sciences
Published: October 07, 2024

Infantile epileptic spasms syndrome: When spasms come out of the blue.

Infantile epileptic spasms syndrome: When spasms come out of the blue.

Journal: Epilepsy & behavior : E&B
Published: July 24, 2024

Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study.

Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study.

Journal: Journal of the neurological sciences
Published: May 27, 2024
Showing 1-12 of 92

Last Updated: 09/26/2026